The Oncosearch | Oncotarget

A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival Research Paper

Colm Keane, Joshua Tobin, Dipti Talaulikar, Michael Green, Pauline Crooks, Sanjiv Jain, Maher Gandhi

Published May 4, 2018 · Vol. 9, No. 34 · pp. 23620-23627

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma Research Paper

Alessandro Broccoli, Beatrice Casadei, Alice Morigi, Federico Sottotetti, Manuel Gotti, Michele Spina, Stefano Volpetti, Simone Ferrero, Francesco Spina, Francesco Pisani, Michele Merli, Carlo Visco, Rossella Paolini, Vittorio Ruggero Zilioli, Luca Baldini, Nicola Di Renzo, Patrizia Tosi, Nicola Cascavilla, Stefano Molica, Fiorella Ilariucci, Gian Matteo Rigolin, Francesco D'AlÃ², Anna Vanazzi, Elisa Santambrogio, Roberto Marasca, Lucia Mastrullo, Claudia Castellino, Giovanni Desabbata, Ilaria Scortechini, Livio Trentin, Lucia Morello, Lisa Argnani, Pier Luigi Zinzani

Published May 4, 2018 · Vol. 9, No. 34 · pp. 23443-23450

Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma Research Paper

Steven F. Chen, Zheng Liu, Shyambabu Chaurasiya, Thanh H. Dellinger, Jianming Lu, Xiwei Wu, Hanjun Qin, Jinhui Wang, Yuman Fong, Yate-Ching Yuan

Published Apr 17, 2018 · Vol. 9, No. 29 · pp. 20451-20466

Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer Research Paper

Cathy B. Moelans, Caroline M.G. van Maldegem, Elsken van der Wall, Paul J. van Diest

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 17078-17092

Incidence and risk factors for venous thromboembolism in patients with pretreated advanced pancreatic carcinoma Research Paper

Shunsuke Kondo, Mitsuhito Sasaki, Hiroko Hosoi, Yasunari Sakamoto, Chigusa Morizane, Hideki Ueno, Takuji Okusaka

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16883-16890

ADAM17 inhibition enhances platinum efficiency in ovarian cancer Research Paper

Nina Hedemann, Christoph Rogmans, Susanne Sebens, Daniela Wesch, Manuel Reichert, Dirk Schmidt-Arras, Hans-Heinrich Oberg, Ulrich Pecks, Marion van Mackelenbergh, JÃ¶rg Weimer, Norbert Arnold, Nicolai Maass, Dirk O. Bauerschlag

Published Mar 23, 2018 · Vol. 9, No. 22 · pp. 16043-16058

Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft Research Paper

Santosh K. Bharti, Yelena Mironchik, Flonne Wildes, Marie-France Penet, Eibhlin Goggins, Balaji Krishnamachary, Zaver M. Bhujwalla

Published Mar 16, 2018 · Vol. 9, No. 20 · pp. 15326-15339

AP-1 confers resistance to anti-cancer therapy by activating XIAP Research Paper

Yuan Wang, Guo-Hui Wan, Ying-Min Wu, Hong-Sheng Wang, Hai-Fang Wang, Ge Zhang, Lin-Lin Lu, Zi-Qian Li, Ka-Ying Chan, Yan Zhou, Shao-Hui Cai, Yi- Fei Qi, Jun Du

Published Mar 6, 2018 · Vol. 9, No. 18 · pp. 14124-14137

Effects of Cetuximab and Erlotinib on the behaviour of cancer stem cells in head and neck squamous cell carcinoma Research Paper

Maria Fernanda SetÃºbal Destro Rodrigues, Luke Gammon, Muhammad M. Rahman, Adrian Biddle, Fabio Daumas Nunes, Ian C. Mackenzie

Published Feb 5, 2018 · Vol. 9, No. 17 · pp. 13488-13500

The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer Review

Chiranjib Chakraborty, Ashish Ranjan Sharma, Garima Sharma, Bimal Kumar Sarkar, Sang-Soo Lee

Published Jan 23, 2018 · Vol. 9, No. 11 · pp. 10164-10174

Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae Research Paper

Roger Sun, Ines Koubaa, Elaine Johanna Limkin, Isabelle Dumas, Enrica Bentivegna, Eduardo Castanon, SÃ©bastien Gouy, Cynthia Baratiny, Fyo Monnot, Pierre Maroun, Samy Ammari, Elise Zareski, Corinne Balleyguier, Ã‰ric Deutsch, Philippe Morice, Christine Haie-Meder, Cyrus Chargari

Published Jan 18, 2018 · Vol. 9, No. 10 · pp. 9299-9310

Identification and characterisation of NANOG+/ OCT-4^high/SOX2+ doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines Research Paper

Reham M. Balahmar, David J. Boocock, Clare Coveney, Sankalita Ray, Jayakumar Vadakekolathu, Tarik Regad, Selman Ali, Shiva Sivasubramaniam

Published Jan 11, 2018 · Vol. 9, No. 6 · pp. 7054-7065

Fucoidan-coated CuS nanoparticles for chemo-and photothermal therapy against cancer Research Paper

Bian Jang, Madhappan Santha Moorthy, Panchanathan Manivasagan, Li Xu, Kyeongeun Song, Kang Dae Lee, Minseok Kwak, Junghwan Oh, Jun-O Jin

Published Jan 3, 2018 · Vol. 9, No. 16 · pp. 12649-12661

Quercitrin suppresses hepatocellular carcinoma metastasis and angiogenesis by targeting the Nrf2 signaling pathway Research Paper

Hong Guang Li, Heng Jun Gao, Fang Feng Liu, Jun Liu

Published Dec 30, 2017 · Vol. 5

A common molecular signature of intestinal-type gastric carcinoma indicates processes related to gastric carcinogenesis Research Paper

Renata Binato, Everton Cruz Santos, Mariana Boroni, Samia Demachki, Paulo AssumpÃ§Ã£o, Eliana Abdelhay

Published Dec 27, 2017 · Vol. 9, No. 7 · pp. 7359-7371

MUC1 induces M2 type macrophage influx during postpartum mammary gland involution and triggers breast cancer Research Paper

Yuan Li, Zhi Pang, Xinran Dong, Xiaodong Liao, Huayun Deng, Chunhua Liao, Yahui Liao, Guoqiang Chen, Lei Huang

Published Dec 15, 2017 · Vol. 9, No. 3 · pp. 3446-3458

Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E₂ and down-regulating the Wnt pathway activity Research Paper

Chaolin Huang, Yuanhong Chen, Hang Liu, Jing Yang, Xuejing Song, Junping Zhao, Na He, Chengji J. Zhou, Yongping Wang, Changjiang Huang, Qiaoxiang Dong

Published Dec 14, 2017 · Vol. 8, No. 70 · pp. 115254-115269

Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models Research Paper

Ying Li, Meng Wang, Pei Zhi, Jian You, Jianqing Gao

Published Dec 8, 2017 · Vol. 9, No. 2 · pp. 2158-2174

Evaluation of the combination of the dual m-TORC1/2 inhibitor vistusertib (AZD2014) and paclitaxel in ovarian cancer models Research Paper

Anne-Christine Wong Te Fong, Parames Thavasu, Sladjana Gagrica, Karen E. Swales, Martin O. Leach, Sabina C. Cosulich, Yuen-Li Chung, Udai Banerji

Published Dec 6, 2017 · Vol. 8, No. 69 · pp. 113874-113884

The inhibition of cordycepin on cancer stemness in TGF-beta induced chemo-resistant ovarian cancer cell Research Paper

Chia-Woei Wang, Bao-Hong Lee, Chen-Jei Tai

Published Dec 5, 2017 · Vol. 8, No. 67 · pp. 111912-111921

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival Research Paper

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma Research Paper

Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma Research Paper

Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer Research Paper

Incidence and risk factors for venous thromboembolism in patients with pretreated advanced pancreatic carcinoma Research Paper

ADAM17 inhibition enhances platinum efficiency in ovarian cancer Research Paper

Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft Research Paper

AP-1 confers resistance to anti-cancer therapy by activating XIAP Research Paper

Effects of Cetuximab and Erlotinib on the behaviour of cancer stem cells in head and neck squamous cell carcinoma Research Paper

The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer Review

Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae Research Paper

Identification and characterisation of NANOG+/ OCT-4^high/SOX2+ doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines Research Paper

Fucoidan-coated CuS nanoparticles for chemo-and photothermal therapy against cancer Research Paper

Quercitrin suppresses hepatocellular carcinoma metastasis and angiogenesis by targeting the Nrf2 signaling pathway Research Paper

A common molecular signature of intestinal-type gastric carcinoma indicates processes related to gastric carcinogenesis Research Paper

MUC1 induces M2 type macrophage influx during postpartum mammary gland involution and triggers breast cancer Research Paper

Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E₂ and down-regulating the Wnt pathway activity Research Paper

Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models Research Paper

Evaluation of the combination of the dual m-TORC1/2 inhibitor vistusertib (AZD2014) and paclitaxel in ovarian cancer models Research Paper

The inhibition of cordycepin on cancer stemness in TGF-beta induced chemo-resistant ovarian cancer cell Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival Research Paper

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma Research Paper

Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma Research Paper

Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer Research Paper

Incidence and risk factors for venous thromboembolism in patients with pretreated advanced pancreatic carcinoma Research Paper

ADAM17 inhibition enhances platinum efficiency in ovarian cancer Research Paper

Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft Research Paper

AP-1 confers resistance to anti-cancer therapy by activating XIAP Research Paper

Effects of Cetuximab and Erlotinib on the behaviour of cancer stem cells in head and neck squamous cell carcinoma Research Paper

The novel strategies for next-generation cancer treatment: miRNA combined with chemotherapeutic agents for the treatment of cancer Review

Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae Research Paper

Identification and characterisation of NANOG+/ OCT-4high/SOX2+ doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines Research Paper

Fucoidan-coated CuS nanoparticles for chemo-and photothermal therapy against cancer Research Paper

Quercitrin suppresses hepatocellular carcinoma metastasis and angiogenesis by targeting the Nrf2 signaling pathway Research Paper

A common molecular signature of intestinal-type gastric carcinoma indicates processes related to gastric carcinogenesis Research Paper

MUC1 induces M2 type macrophage influx during postpartum mammary gland involution and triggers breast cancer Research Paper

Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2 and down-regulating the Wnt pathway activity Research Paper

Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models Research Paper

Evaluation of the combination of the dual m-TORC1/2 inhibitor vistusertib (AZD2014) and paclitaxel in ovarian cancer models Research Paper

The inhibition of cordycepin on cancer stemness in TGF-beta induced chemo-resistant ovarian cancer cell Research Paper

Identification and characterisation of NANOG+/ OCT-4^high/SOX2+ doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines Research Paper

Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E₂ and down-regulating the Wnt pathway activity Research Paper